Bradley’s Public Comment on the New DEA Teleprescribing Rules
New rules on prescribing controlled substances via telehealth threaten access to care for children and teenagers with ADHD.
“In our high-risk population, delays in obtaining appropriate medication can contribute to a life-threatening situation. When we prescribe stimulants to pediatric patients, they are always used under parental supervision.”
Read Bradley REACH’s public statement on the rule change below.